5
IRUS TotalDownloads
Altmetric
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia
| File | Description | Size | Format | |
|---|---|---|---|---|
 s41375-023-02048-y.pdf | Published version | 1.57 MB | Adobe PDF | View/Open |
| Title: | European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia |
| Authors: | Cross, NCP Ernst, T Branford, S Cayuela, J-M Deininger, M Fabarius, A Kim, DDH Machova Polakova, K Radich, JP Hehlmann, R Hochhaus, A Apperley, JF Soverini, S |
| Item Type: | Journal Article |
| Abstract: | From the laboratory perspective, effective management of patients with chronic myeloid leukemia (CML) requires accurate diagnosis, assessment of prognostic markers, sequential assessment of levels of residual disease and investigation of possible reasons for resistance, relapse or progression. Our scientific and clinical knowledge underpinning these requirements continues to evolve, as do laboratory methods and technologies. The European LeukemiaNet convened an expert panel to critically consider the current status of genetic laboratory approaches to help diagnose and manage CML patients. Our recommendations focus on current best practice and highlight the strengths and pitfalls of commonly used laboratory tests. |
| Issue Date: | Nov-2023 |
| Date of Acceptance: | 20-Sep-2023 |
| URI: | http://hdl.handle.net/10044/1/107176 |
| DOI: | 10.1038/s41375-023-02048-y |
| ISSN: | 0887-6924 |
| Publisher: | Springer Nature [academic journals on nature.com] |
| Start Page: | 2150 |
| End Page: | 2167 |
| Journal / Book Title: | Leukemia |
| Volume: | 37 |
| Issue: | 11 |
| Copyright Statement: | © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| Publication Status: | Published |
| Conference Place: | England |
| Online Publication Date: | 2023-10-04 |
| Appears in Collections: | Department of Immunology and Inflammation Faculty of Medicine |
This item is licensed under a Creative Commons License
